Study of Standard and Individualized Treatment Model for Relapse and Refractory Lymphatic System Malignant Tumors
The purpose of the study is to research the standard and individualized treatment model for relapse and refractory lymphatic system malignant tumors.
Lymphoma
OTHER: Hematopoietic stem cell transplantation
overall response rate, 2 years after treatment|complete response, 2 years after treatment|progression-free survival, 2 years after treatment|overall survival, 2 years after treatment
The purpose of the study is to research the standard and individualized treatment model for relapse and refractory lymphatic system malignant tumors.